Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $47,678 - $62,239
-1,142 Reduced 15.74%
6,114 $313,000
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $13,434 - $16,399
-307 Reduced 4.06%
7,256 $318,000
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $655,561 - $777,290
-14,089 Reduced 65.07%
7,563 $397,000
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $405,756 - $502,783
8,869 Added 69.38%
21,652 $1.12 Million
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $33,427 - $49,551
-809 Reduced 5.95%
12,783 $755,000
Q3 2021

Oct 22, 2021

SELL
$39.25 - $50.42 $2,904 - $3,731
-74 Reduced 0.54%
13,592 $585,000
Q2 2021

Jul 29, 2021

SELL
$35.91 - $40.68 $24,921 - $28,231
-694 Reduced 4.83%
13,666 $535,000
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $61,420 - $69,270
-1,834 Reduced 11.33%
14,360 $520,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $71,247 - $83,589
-2,244 Reduced 12.17%
16,194 $594,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $3,915 - $4,750
-130 Reduced 0.7%
18,438 $603,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $85,063 - $121,537
-3,147 Reduced 14.49%
18,568 $712,000
Q4 2019

Jan 27, 2020

SELL
$32.92 - $37.36 $51,849 - $58,842
-1,575 Reduced 6.76%
21,715 $851,000
Q3 2019

Dec 02, 2019

SELL
$32.49 - $42.13 $116,509 - $151,078
-3,586 Reduced 13.34%
23,290 $837,000
Q2 2019

Nov 27, 2019

SELL
$36.98 - $41.52 $120,148 - $134,898
-3,249 Reduced 10.79%
26,876 $1.16 Million
Q1 2019

Nov 27, 2019

SELL
$37.5 - $41.2 $216,375 - $237,724
-5,770 Reduced 16.07%
30,125 $1.28 Million
Q4 2018

Nov 27, 2019

BUY
$38.47 - $43.86 $1.38 Million - $1.57 Million
35,895 New
35,895 $1.57 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.